These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34726371)

  • 1. Peptoid Nanosheet-Based Sensing System for the Diagnosis and Surveillance of Amnestic Mild Cognitive Impairment and Alzheimer's Disease.
    Gao H; Wang J; Liu J; Ye S; Meng X; Song S; Wang C; Yu X; Zhu L; Wang H; Lei S; Yang Y
    ACS Chem Neurosci; 2021 Nov; 12(22):4257-4264. PubMed ID: 34726371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by the Plasma and Serum Amyloid-beta 42 Assay through Highly Sensitive Peptoid Nanosheet Sensor.
    Gao H; Liu M; Zhao Z; Yang C; Zhu L; Cai Y; Yang Y; Hu Z
    ACS Appl Mater Interfaces; 2020 Feb; 12(8):9693-9700. PubMed ID: 32013375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-Mimetic Peptoid Nanosheet for Label-Free Serum-Based Diagnosis of Alzheimer's Disease.
    Zhu L; Zhao Z; Cheng P; He Z; Cheng Z; Peng J; Wang H; Wang C; Yang Y; Hu Z
    Adv Mater; 2017 Aug; 29(30):. PubMed ID: 28605073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Aβ42 as a Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study.
    Albani D; Marizzoni M; Ferrari C; Fusco F; Boeri L; Raimondi I; Jovicich J; Babiloni C; Soricelli A; Lizio R; Galluzzi S; Cavaliere L; Didic M; Schönknecht P; Molinuevo JL; Nobili F; Parnetti L; Payoux P; Bocchio L; Salvatore M; Rossini PM; Tsolaki M; Visser PJ; Richardson JC; Wiltfang J; Bordet R; Blin O; Forloni G; Frisoni GB;
    J Alzheimers Dis; 2019; 69(1):37-48. PubMed ID: 30149449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood biomarkers for the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis.
    Qu Y; Ma YH; Huang YY; Ou YN; Shen XN; Chen SD; Dong Q; Tan L; Yu JT
    Neurosci Biobehav Rev; 2021 Sep; 128():479-486. PubMed ID: 34245759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep spindles, K-complexes, limb movements and sleep stage proportions may be biomarkers for amnestic mild cognitive impairment and Alzheimer's disease.
    Liu S; Pan J; Tang K; Lei Q; He L; Meng Y; Cai X; Li Z
    Sleep Breath; 2020 Jun; 24(2):637-651. PubMed ID: 31786748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Expression Profile of Phosphatidylinositols in Erythrocytes of Alzheimer's Disease and Amnestic Mild Cognitive Impairment Patients.
    Chen Y; Lin C; Guo Z; Zhao S; Zhu Y; Huang F; Shui G; Lam SM; Pu J; Yan Y; Liu Z; Zhang B
    J Alzheimers Dis; 2020; 73(2):811-818. PubMed ID: 31868671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of CSF Biomarkers in Predicting the Progression of Amnesic and Nonamnesic Mild Cognitive Impairment to Alzheimer's Disease.
    Ortega RL; Dakterzada F; Arias A; Blasco E; Naudí A; Garcia FP; Piñol-Ripoll G
    Curr Aging Sci; 2019; 12(1):35-42. PubMed ID: 31589110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hard Test Your Memory. Evaluation of a short cognitive test to detect mild Alzheimer's disease and amnestic mild cognitive impairment.
    Brown JM; Wiggins J; Dong H; Harvey R; Richardson F; Hunter K; Dawson K; Parker RA
    Int J Geriatr Psychiatry; 2014 Mar; 29(3):272-80. PubMed ID: 23929807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Label-free detection of Alzheimer's disease through the ADP3 peptoid recognizing the serum amyloid-beta42 peptide.
    Zhao Z; Zhu L; Bu X; Ma H; Yang S; Yang Y; Hu Z
    Chem Commun (Camb); 2015 Jan; 51(4):718-21. PubMed ID: 25418132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease.
    Marizzoni M; Ferrari C; Macis A; Jovicich J; Albani D; Babiloni C; Cavaliere L; Didic M; Forloni G; Galluzzi S; Hoffmann KT; Molinuevo JL; Nobili F; Parnetti L; Payoux P; Pizzini F; Rossini PM; Salvatore M; Schönknecht P; Soricelli A; Del Percio C; Hensch T; Hegerl U; Tsolaki M; Visser PJ; Wiltfang J; Richardson JC; Bordet R; Blin O; Frisoni GB;
    J Alzheimers Dis; 2019; 69(1):49-58. PubMed ID: 30958351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High avidity HSV-1 antibodies correlate with absence of amnestic Mild Cognitive Impairment conversion to Alzheimer's disease.
    Agostini S; Mancuso R; Baglio F; Cabinio M; Hernis A; Costa AS; Calabrese E; Nemni R; Clerici M
    Brain Behav Immun; 2016 Nov; 58():254-260. PubMed ID: 27470229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters.
    Monacelli F; Borghi R; Cammarata S; Nencioni A; Piccini A; Tabaton M; Odetti P
    J Alzheimers Dis; 2015; 45(1):89-95. PubMed ID: 25471189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous K-Complexes may be biomarkers of the progression of amnestic mild cognitive impairment.
    Liu S; Pan J; Lei Q; He L; Zhong B; Meng Y; Li Z
    Sleep Med; 2020 Mar; 67():99-109. PubMed ID: 31918124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic potential of urinary monocyte chemoattractant protein-1 for Alzheimer's disease and amnestic mild cognitive impairment.
    Xu Y; Shen YY; Zhang XP; Gui L; Cai M; Peng GP; Pan XD; Zhang J; Gan D; Li B; Cheng HP; Deng J; Li WW; Zeng GH; Shi AY; Zhou ZH; Luo BY; Chen XC; Wang YJ
    Eur J Neurol; 2020 Aug; 27(8):1429-1435. PubMed ID: 32282975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological and neuroimaging characteristics of amnestic mild cognitive impairment subtypes: a selective overview.
    Li X; Zhang ZJ
    CNS Neurosci Ther; 2015 Oct; 21(10):776-83. PubMed ID: 25809732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of odors, faces, cities and naming of objects in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer´s disease: a longitudinal study.
    Tahmasebi R; Zehetmayer S; Pusswald G; Kovacs G; Stögmann E; Lehrner J
    Int Psychogeriatr; 2019 Apr; 31(4):537-549. PubMed ID: 30236169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline.
    Eliassen CF; Reinvang I; Selnes P; Grambaite R; Fladby T; Hessen E
    Brain Behav; 2017 Sep; 7(9):e00776. PubMed ID: 28948074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of blood biomarkers for Alzheimer's disease and amnestic mild cognitive impairment: A meta-analysis.
    Chen YR; Liang CS; Chu H; Voss J; Kang XL; O'Connell G; Jen HJ; Liu D; Shen Hsiao ST; Chou KR
    Ageing Res Rev; 2021 Nov; 71():101446. PubMed ID: 34391944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.